RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-24-3662
Affiliations:
6
Authors:
20
Go to article
Institutions Authors Share
Genentech, Inc., United States of America (USA)
20.000000
20.000000
20.000000
 1.00
Interested in Oncology and Carcinogenesis?